银屑病关节炎胸锁关节受累是疾病严重程度的隐藏指标
该研究回顾性分析1737例银屑病关节炎(PsA)患者的前瞻性队列数据,182例(10.5%)存在胸锁关节(SCJ)受累,其中36例(2.1%)随访期间曾出现临床肿胀。SCJ肿胀在多变量分析中与更高肿胀关节数(OR 1.08)、附着点炎(OR 4.54)、指趾炎(OR 4.54)及较低生物制剂或靶向合成DMARD使用(OR 0.30)相关。
要点
- PsA患者中SCJ受累占10.5%,临床肿胀SCJ占2.1%,33.1%在基线即存在。
- SCJ肿胀与更高SJC、附着点炎和指趾炎独立相关。
- SCJ肿胀与较低生物制剂或靶向合成DMARD使用相关(OR 0.30)。
核心结论
- SCJ受累是PsA被低估但有临床意义的表現,与更大疾病负担和附着点炎相关,常需升级至先进治疗。
研究设计与样本
- 回顾性分析Gladman Krembil银屑病关节炎项目前瞻性收集的数据,共1737例PsA患者。
主要发现
- 182例(10.5%)有SCJ受累,其中36例(2.1%)随访期间曾临床肿胀SCJ,33.1%的受累者在基线即存在。
- 单变量分析中SCJ受累与更高SJC(OR 1.142,95%CI 1.08-1.16)、指趾炎(OR 4.51,95%CI 2.02-10.05)、附着点炎(OR 6.74,95%CI 3.45-13.15)显著相关。
- 与性别、病程、中轴和指甲病变、PASI、脓疱型银屑病或HLA标志物无显著关联。
- 多变量分析中SCJ肿胀仍与更高SJC(OR 1.08,95%CI 1.03-1.14)、附着点炎(OR 4.54,95%CI 1.98-10.45)、指趾炎(OR 4.54,95%CI 1.98-10.45)及较低生物制剂或靶向合成DMARD使用(OR 0.30,95%CI 0.10-0.88)相关。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Sternoclavicular joint (SCJ) involvement in PsA is poorly characterized. We aimed to assess its prevalence and clinical associations in a longitudinal PsA cohort. METHODS: We retrospectively analysed prospectively collected data from the Gladman Krembil Psoriatic Arthritis Program. Patients with SCJ involvement (tender and/or swollen SCJ) were identified, and their demographic, clinical, laboratory and treatment details were retrieved. Univariable and multivariable generalized estimating equation models were used to assess associations with clinically swollen SCJ. Results are reported as odds ratios (OR) with 95% CI. RESULTS: Among the 1737 patients, 182 (10.5%) had SCJ involvement, including 36 (2.1%) with clinically swollen SCJs ever over follow-up. SCJ involvement was present at enrolment into the cohort (baseline) in 33.1% of affected individuals. The mean age was 41.4 ± 12 years, and 42% were male. In univariable analyses, SCJ involvement was significantly associated with higher swollen joint count (SJC) (OR 1.142, 95% CI 1.08-1.16), dactylitis (4.51, 2.02-10.05) and enthesitis (6.74, 3.45-13.15). No significant associations were observed with sex, disease duration, axial and nail disease, PASI, pustular psoriasis or HLA markers. In multivariable analysis, SCJ swelling remained associated with higher SJC (1.08, 1.03-1.14), enthesitis (4.54, 1.98-10.45), dactylitis (4.54, 1.98-10.45) and lower biologic or targeted synthetic DMARD use (0.30, 0.10-0.88). CONCLUSION: SCJ involvement is an underrecognized but clinically meaningful manifestation of PsA, associated with greater disease burden and enthesitis, often requiring escalation to advanced therapies.
引用
- Mehta P, Kharouf F, Carrizo Abarza V, et al. Sternoclavicular joint involvement in psoriatic arthritis: a hidden indicator of disease severity. Rheumatology (Oxford). 2026. PMID: 41284674. doi:10.1093/rheumatology/keaf583
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。